NCT04632459 2026-06-05Pembrolizumab Plus Ramucirumab in Metastatic Gastric CancerSamsung Medical CenterPhase 2 Completed26 enrolled 9 charts
NCT04145349 2026-05-11CAMPFIRE: A Study of Ramucirumab (LY3009806) in Children and Young Adults With Desmoplastic Small Round Cell TumorEli Lilly and CompanyPhase 1/2 Completed30 enrolled 16 charts